Prospective study of pulmonary infections in patients with rheumatic diseases undergoing immunosuppressive therapy

Not Applicable

• Conditions: rheumatoid arthritis (including rheumatoid arthritis with vasculitis), systemic lupus erythematosus, polymyositis, dermatomyositis, systemic sclerosis, mixed connective tissue disease, vasculitis syndrome, primary Sjogren' s syndrome, Bechet disease, adult onset Still' s disease

• Registration Number: JPRN-UMIN000001200
• Lead Sponsor: Department of Medicine and Rheumatology, Tokyo Medical and Dental University Graduate School

Brief Summary

one

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-01
• Study Completion: 2011-06-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Not provided

Exclusion Criteria

1.When patients withdraw consent to join the study. 2.When an attending doctor judges that enrollment of a patient is inappropriate 3.When patients participate in a clinical trial for approval of a drug in Japan.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Predictive factors of pulmonary infections

Secondary Outcome Measures

Name	Time	Method
Association of pulmonary infection with survival rate Implementation and effectiveness of prophylaxis for Pneumocystis pneumonia Implementation and effectiveness of prophylaxis for M. tuberculosis Implementation and effectiveness of vaccination for Streptococcus pneumoniae